Literature DB >> 26622553

miR-125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K/AKT/mTOR signaling pathway.

Hao Tang1, Rong-Ping Li2, Ping Liang3, Ya-Long Zhou1, Guang-Wei Wang1.   

Abstract

In order to explore the regulation of the invasive ability of hepatocellular carcinoma cells and the underlying mechanism, mimics sequences of microRNA (miR)-125a (miR-125a-3p/5p) and scramble sequences (miR-125a-3p-s/5p-s) were transfected into human hepatocellular carcinoma cell lines, HCC-LM3 and HepG2, and the non-malignant epithelioid hepatic cell line QZG. To inhibit and upregulate the expression of miR-125a individually. Protein expression was detected by western blotting, and the cell proliferation and migration abilities were evaluated by soft agar colony formation and Transwell assay, respectively. It was revealed that the expression of miR-125a was downregulated in HepG2 and HCC-LM3 cells compared with that of QZG cells, and expression was markedly lower in HCC-LM3 cells than that in HepG2 cells (P<0.01). The colony formation and migration rates of the cells transfected with miR-125a-3p/5p were decreased compared with negative controls, but were increased in cells transfected with miR-125a-3p-3/5p-s (P<0.01). The protein and messenger RNA expression of phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) was decreased following transfection with miR-125a-5p, whereas expression was increased compared with negative controls following transfection with miR-125a-5p-s (P<0.01). Furthermore, the proliferation and migration abilities of cells were attenuated following inhibition of the PI3K/AKT/mTOR pathway by LY294002. The results of the present study indicated that miR-125a inhibits the invasive ability of hepatocellular carcinoma cells via regulation of the PI3K/AKT/mTOR pathway.

Entities:  

Keywords:  AKT; hepatocellular carcinoma; invasion; mammalian target of rapamycin; microRNA-125a; phosphoinositide 3-kinase

Year:  2015        PMID: 26622553      PMCID: PMC4509408          DOI: 10.3892/ol.2015.3264

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  29 in total

1.  Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b.

Authors:  Gary K Scott; Andrei Goga; Dipa Bhaumik; Crystal E Berger; Christopher S Sullivan; Christopher C Benz
Journal:  J Biol Chem       Date:  2006-11-16       Impact factor: 5.157

2.  A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma.

Authors:  Ge Gao; Hiram A Gay; Rebecca D Chernock; Tian R Zhang; Jingqin Luo; Wade L Thorstad; James S Lewis; Xiaowei Wang
Journal:  Cancer       Date:  2012-06-26       Impact factor: 6.860

3.  MPHOSPH1: a potential therapeutic target for hepatocellular carcinoma.

Authors:  Xinran Liu; Yafan Zhou; Xinyuan Liu; Anlin Peng; Hao Gong; Lizi Huang; Kaige Ji; Robert B Petersen; Ling Zheng; Kun Huang
Journal:  Cancer Res       Date:  2014-09-30       Impact factor: 12.701

Review 4.  MicroRNA regulation by RNA-binding proteins and its implications for cancer.

Authors:  Marieke van Kouwenhove; Martijn Kedde; Reuven Agami
Journal:  Nat Rev Cancer       Date:  2011-08-05       Impact factor: 60.716

5.  Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.

Authors:  Yojiro Hashiguchi; Naohiro Nishida; Koshi Mimori; Tomoya Sudo; Fumiaki Tanaka; Kohei Shibata; Hideshi Ishii; Hidetaka Mochizuki; Kazuo Hase; Yuichiro Doki; Masaki Mori
Journal:  Int J Oncol       Date:  2012-02-09       Impact factor: 5.650

Review 6.  Molecular therapies in hepatocellular carcinoma: what can we target?

Authors:  Roberto Galuppo; Dinesh Ramaiah; Oscar Moreno Ponte; Roberto Gedaly
Journal:  Dig Dis Sci       Date:  2014-02-27       Impact factor: 3.199

7.  Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.

Authors:  Lili Jiang; Qin Huang; Siyang Zhang; Qingfu Zhang; Jihong Chang; Xueshan Qiu; Enhua Wang
Journal:  BMC Cancer       Date:  2010-06-22       Impact factor: 4.430

8.  Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF.

Authors:  Qian Bi; Shanhong Tang; Lin Xia; Rui Du; Rui Fan; Liucun Gao; Jiang Jin; Shuhui Liang; Zheng Chen; Guanghui Xu; Yongzhan Nie; Kaichun Wu; Jie Liu; Yongquan Shi; Jie Ding; Daiming Fan
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

9.  Epidermal growth factor receptor-regulated miR-125a-5p--a metastatic inhibitor of lung cancer.

Authors:  Guofu Wang; Weimin Mao; Shu Zheng; Jingjia Ye
Journal:  FEBS J       Date:  2009-08-21       Impact factor: 5.542

10.  Liver microRNA hsa-miR-125a-5p in HBV chronic infection: correlation with HBV replication and disease progression.

Authors:  Nicola Coppola; Nicoletta Potenza; Mariantonietta Pisaturo; Nicola Mosca; Gilda Tonziello; Giuseppe Signoriello; Vincenzo Messina; Caterina Sagnelli; Aniello Russo; Evangelista Sagnelli
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

View more
  37 in total

1.  Comparative analysis of hepatic miRNA levels in male marathon mice reveals a link between obesity and endurance exercise capacities.

Authors:  Daniela Ohde; Julia Brenmoehl; Christina Walz; Armin Tuchscherer; Elisa Wirthgen; Andreas Hoeflich
Journal:  J Comp Physiol B       Date:  2016-06-09       Impact factor: 2.200

2.  The miR-125a-3p Inhibits TIM-3 Expression in AML Cell Line HL-60 In Vitro.

Authors:  Fatemeh Emamdoost; Hossein Khanahmad; Mazdak Ganjalikhani-Hakemi; Abbas Doosti
Journal:  Indian J Hematol Blood Transfus       Date:  2016-10-06       Impact factor: 0.900

3.  MiR-125b-5p suppresses the bladder cancer progression via targeting HK2 and suppressing PI3K/AKT pathway.

Authors:  Shuo Liu; Qin Chen; Yue Wang
Journal:  Hum Cell       Date:  2019-10-11       Impact factor: 4.174

4.  MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.

Authors:  Abdel-Rahman N Zekri; Enas Reda El-Sisi; Amira Salah El-Din Youssef; Mahmoud M Kamel; Auhood Nassar; Ola Sayed Ahmed; Mohamed El Kassas; Ahmed Barakat Barakat; Alaa Ismail Abd El-Motaleb; Abeer A Bahnassy
Journal:  PLoS One       Date:  2018-03-13       Impact factor: 3.240

5.  TGF-β1 signaling pathway serves a role in HepG2 cell regulation by affecting the protein expression of PCNA, gankyrin, p115, XIAP and survivin.

Authors:  Xin-Hong Wang; Zhi-Guo Chen; Rui-Ling Xu; Cheng-Qian Lv; Jing Liu; Bing Du
Journal:  Oncol Lett       Date:  2017-03-06       Impact factor: 2.967

6.  Lens culinaris agglutinin inhibits human hepatoma cell migration via mannose and fucose-mediated ERK1/2 and JNK1/2/3 signalling pathway.

Authors:  Haoran Jiang; Xianxin Wen; Xue Zhang; Xianhua Zhong; Zhangyong Li; Bingyu Zhang
Journal:  Mol Biol Rep       Date:  2022-06-18       Impact factor: 2.742

Review 7.  Targeting autophagy in chemotherapy-resistant of hepatocellular carcinoma.

Authors:  Jiyao Sheng; Hanjiao Qin; Kun Zhang; Bingjin Li; Xuewen Zhang
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

8.  HULC functions as an oncogene in ovarian carcinoma cells by negatively modulating miR-125a-3p.

Authors:  Ping Chu; Lina Xu; Haiying Su
Journal:  J Physiol Biochem       Date:  2019-03-13       Impact factor: 4.158

Review 9.  Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects.

Authors:  Run-Ze Shang; Shi-Bin Qu; De-Sheng Wang
Journal:  World J Gastroenterol       Date:  2016-12-07       Impact factor: 5.742

Review 10.  Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway.

Authors:  Mengnan Guo; Ning Li; Jianxia Zheng; Wei Wang; Yan Wu; Xu Han; Jiapei Guo; Weixi Chen; Zekun Bai; Wen Bai; Jinghua Wu
Journal:  Can J Gastroenterol Hepatol       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.